This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
Drug Dev

Medicxi outlines growth ambitions for MG1 fund

Posted by on 15 March 2018
Share this article

Medicxi has made two investments to date from the $300M growth fund MG1 which it announced in 2017. Speaking at BIO-Europe Spring in Amsterdam, Medicxi Principal Giovanni Mariggi explained to Scrip how the fund selects assets to back.

Share this article

Related Articles

Biotech Showcase™ 2019

China Bio: Change and opportunity are constant

Read More
east
Read More
east
Digital Medicine & Medtech Showcase 2020

What's shaping the future of biotech?

Read More
east
Read More
east
View all related articleseast

Related Event

BIO-Europe

  • 3 Nov, 2025
  • 3 days
  • Vienna, Austria
Book Now
east
Book Now
east

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down
Subscribeeast